Viewing Study NCT03105024



Ignite Creation Date: 2024-05-06 @ 9:55 AM
Last Modification Date: 2024-10-26 @ 12:21 PM
Study NCT ID: NCT03105024
Status: COMPLETED
Last Update Posted: 2018-04-11
First Post: 2017-03-27

Brief Title: Self-efficacy Enhancement and Exposure Therapy
Sponsor: Ruhr University of Bochum
Organization: Ruhr University of Bochum

Study Overview

Official Title: Enhancing Exposure the Impact of Self-efficacy Enhancement on Treatment Outcome
Status: COMPLETED
Status Verified Date: 2018-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Self-efficacy refers to the perceived belief to cope effectively by personal efforts with challenging situations and problems Bandura 1977 Basic research has shown that increases in perceived self-efficacy can enhance the extinction of fear Zlomuzica et al 2015 This study is aimed at translating these findings into a useful clinical application to augment exposure-based treatment outcome
Detailed Description: In this study the effects of self-efficacy enhancement on treatment outcome in patients with height phobia will be investigated

Participants will be randomly assigned to one of the following conditions i virtual reality exposure self-efficacy enhancement ii virtual reality exposure control intervention iii virtual reality exposure only The amount of exposure is identical across groups ie maximum of 1 hour of exposure The self-efficacy and the control intervention involve the retrieval of the exposure session with or without a focus on personal mastery experiencesachievements respectively

Treatment-induced changes as well as the effects of self-efficacy enhancement will be measured on the subjective level ie in-vivo Behavioral Approach Tests BATs church tower physiological level heart rate during the BATs and subjective level subjective fear during the BATs as well as height-phobia related questionnaires at each of the three assessments ie pretreatment after which the exposure will conducted on the same day ie day 1 posttreatment which is scheduled approximately 2-3 days after exposure and follow-up assessment which will take place 1-month after exposure

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None